ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 398

Muscle Function and Health-Related Quality of Life in Patients with Polymyositis and Dermatomyositis

Kristofer Andreasson1, Li Alemo Munters1,2 and Helene Alexanderson3,4, 1Karolinska University Hospital, Function Area Occupational therapy and Physical therapy, Stockholm, Sweden, 2Swedish Rheumatism Association, Stockholm, Sweden, 3Department of NVS, Division of Physical Therapy, Karolinska Institutet, Huddinge, Sweden, 4Function Area Occupational therapy & Physiotherapy, Allied Health Professionals Function, Karolinska University Hospital, Stockholm, Sweden

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Muscle strength, polymyositis/dermatomyositis (PM/DM) and quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Muscle Biology, Myositis and Myopathies Poster – ARHP

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Poly- and dermatomyositis (PM/DM) are idiopathic inflammatory muscle diseases characterized by reduced muscle function. Oral glucocorticoids and DMARD’s are the usual treatment options and physical exercise plays an important role in the treatment as well. Despite an often beneficial effect of treatment, most patients are left with sustained muscle impairment and reduced quality of life. It is not known how muscle impairment differ between patients with newly onset PM/DM and patients with established PM/DM. The aim of this study is to investigate muscle function as to maximal isometric strength (MVIC) and isometric muscular endurance (ME) in patients with newly onset, active and established PM/DM. A further aim is to investigate possible correlations between muscle function and health related quality of life (HRQoL).

Methods: All patients diagnosed with PM or DM (n=5, all female) during 170901 and 180401 at Karolinska University hospital in Solna who met the inclusion criteria were asked to participate. Patients with established PM/DM (n=6, all female) where identified through patient register at the same clinic, selected to match recent onset disease group as to age and gender. A dynamometer from Biodex was used to assess MVIC and ME starting with three warm-up 4-sec contractions followed by three similar maximal contractions, all with a 3-minute rest in-between. Thereafter six sets of twelve submaximal repetitions, starting on 20 % of MVIC and increasing by 10 %/set, finishing on 70 % of MVIC. Each set ended with a new maximal contraction registered as percentage of initial MVIC. The participants reported HRQoL using SF–36. Statistical significance was set to p<0.05, Mann-Whitney U-test was used to compare groups and Spearman’s rho for correlations.

Results: Median age for patients with recent onset PM/DM was 36 (min–max 19–64) years and for established disease 61 (42–66) years. Diagnosis duration was 4 (1–6) months and 126 (85–433) for the two groups, respectively. Patients with recent onset disease had a median MVIC of 73 (53–127) Nm and patients with established disease had 58 (41–82) Nm (p=0.22). ME were 83 (63–94) % and 91 (85–98) % for patients with recent onset disease and established PM/DM, respectively (p=0.08). The correlations between ME and General Health was (rs=0.54, CI=-0.08–0.87) with correlations to Physical Function, Physical Role Function, and Social Function varying between (rs=0.40, CI=-0.26–0.81) and (rs=0.48, CI=-0.17–0.84). Correlations between MVIC and Vitality, Physical Role function, Emotional Function and Social Function varied between (rs=-0.49, CI=-0.84–0.16) and (rs=-0.34, CI=-0.78–0.33). Correlations to remaining domains were lower.

Conclusion: No significant differences were found between the groups regarding MVIC and ME. However, there was a trend towards reduced ME in patients with recent onset PM/DM compared to established disease. Correlations between muscle function and HRQoL were moderate at best. Further research is needed with more patients to reach statistical power and improved matching of patients and controls.


Disclosure: K. Andreasson, None; L. Alemo Munters, None; H. Alexanderson, None.

To cite this abstract in AMA style:

Andreasson K, Alemo Munters L, Alexanderson H. Muscle Function and Health-Related Quality of Life in Patients with Polymyositis and Dermatomyositis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/muscle-function-and-health-related-quality-of-life-in-patients-with-polymyositis-and-dermatomyositis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/muscle-function-and-health-related-quality-of-life-in-patients-with-polymyositis-and-dermatomyositis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology